Fishers, IN, United States of America

Renhua Li



 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: **Renhua Li: Innovator in Antibody-Drug Conjugates and mGluR Antagonists**

Introduction

Renhua Li, located in Fishers, Indiana, is a prominent inventor renowned for his significant contributions to the field of biotechnology. With a remarkable portfolio of 8 patents, Li has demonstrated a persistent commitment to advancing medical therapies through innovative research.

Latest Patents

Among his latest innovations are two notable patents. The first is for MET antibody drug conjugates, which provide groundbreaking solutions for targeting and destroying MET expressing tumor cells, thereby offering potential treatments for MET expressing cancers. This patent encompasses novel compounds and methods for conjugating MET antibodies to create these effective antibody-drug conjugates. The second patent features 4-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds that serve as mGluR 2/3 antagonists. It describes the formulation, uses, and preparation methods for this mGlu2/3 receptor antagonist.

Career Highlights

Renhua Li is currently employed at Eli Lilly and Company, where he applies his expertise to enhance pharmaceutical research and development. His work with antibody-drug conjugates and receptor antagonists has placed him at the forefront of cancer treatment innovations, making significant strides in the healthcare industry.

Collaborations

Throughout his career, Renhua Li has collaborated with several talented individuals, including coworkers Owen Brendan Wallace and Yanping Xu. These partnerships highlight the collaborative spirit essential for driving innovation in complex scientific fields.

Conclusion

In summary, Renhua Li exemplifies the qualities of a dedicated inventor and innovator. His contributions to the development of advanced therapeutic compounds not only underscore his expertise but also represent a promising future for patients affected by various cancers. Through his work at Eli Lilly and Company, Li continues to make impactful advancements in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…